UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

|X|   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

                For the quarterly period ended September 30, 2005

|_|   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

                For the transition period from________ to ___________

                         Commission File No. 333-105840


                         MEDICAL MEDIA TELEVISION, INC.
        (Exact Name of Small Business Issuer as Specified in Its Charter)


            Florida                                       59-3459320
            -------                                       ----------
(State or Other Jurisdiction of             (I.R.S. Employer Identification No.)
Incorporation or Organization)

                           8406 Benjamin Road, Suite C
                              Tampa, Florida 33634
                              --------------------
                    (Address of Principal Executive Offices)


                                 (813) 888-7330
                                 --------------
                           (Issuer's Telephone Number)



--------------------------------------------------------------------------------
              (Former Name, Former Address and Former Fiscal Year,
                         if Changed Since Last Report)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

                                    Yes [X]  No [ ]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).
                                    Yes [ ]  No [X]

The number of shares outstanding of the Registrant's common stock as of November
21, 2005 was 20,725,104.


Transitional Small Business Disclosure Format:

                                    Yes [ ] No [X]

================================================================================

<PAGE>

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

In the opinion of management, the accompanying unaudited financial statements
included in this Form 10-QSB reflect all adjustments (consisting only of normal
recurring accruals) necessary for a fair presentation of the results of
operations for the periods presented. The results of operations for the periods
presented are not necessarily indicative of the results to be expected for the
full year.

<TABLE>
<CAPTION>
<S>                                                                                <C>
Accountants' Review Report                                                              3


Balance Sheets as of September 30, 2005 and December 31, 2004                           4


Statements of Operations for the three and nine months ended September 30, 2005
and 2004, and from inception (October 2, 1989) through September 30, 2005 5


Statements of Changes in Stockholders' Equity from inception (October 2, 1989)
through September 30, 2005                                                              6


Statements of Cash Flows for the nine months ended September 30, 2005 and 2004,
and from inception (October 2, 1989) through September 30, 2005 7


Notes to the Financial
Statements                                                                           8-21

</TABLE>



                                       2

<PAGE>

                         BAUMANN, RAYMONDO & COMPANY PA
                         405 North Reo Street, Suite 200
                              Tampa, Florida 33609
                                  (813)288-8826


             Report of Independent Registered Public Accounting Firm


Board of Directors
Medical Media Television, Inc.
Tampa, Florida

We have reviewed the accompanying consolidated balance sheet of Medical Media
Television, Inc. as of September 30, 2005, and the related consolidated
statements of operations, stockholders' equity and cash flows for the three- and
nine-month periods then ended. These consolidated financial statements are the
responsibility of the Company's management.

We conducted our reviews in accordance with the standards of the Public Company
Accounting Oversight Board (United States). A review of interim financial
information consists principally of applying analytical procedures to financial
data and making inquiries of persons responsible for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with the standards of the Public Company Accounting Oversight Board, the
objective of which is the expression of an opinion regarding the financial
statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to such consolidated financial statements for them to be in conformity
with U.S. generally accepted accounting principles.

As discussed in Note A, the Company has been in the development stage since its
inception on October 2, 1989. Realization of a major portion of its assets is
dependent on the Company's ability to meet its future financing requirements,
and the success of its future operations. These factors raise substantial doubt
about the Company's ability to continue as a going concern.


/s/ Baumann Raymondo & Company PA
BAUMANN RAYMONDO & COMPANY PA
November 21, 2005

                                       3

<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                           CONSOLIDATED BALANCE SHEET


<TABLE>
<CAPTION>
                                                                             September 30,     December 31,
                                                                                 2005             2004
                                       ASSETS                                 Unaudited          Audited
                                                                             -----------       -----------
Current assets:
<S>                                                                          <C>               <C>
    Cash                                                                     $    16,511       $    18,793
    Accounts receivable, net of reserves                                            --               9,470
    Prepaid expenses                                                              43,143            77,374
    Other receivables                                                              9,583               871
                                                                             -----------       -----------
         Total current assets                                                     69,237           106,508
                                                                             -----------       -----------
Fixed assets:
    Computer equipment                                                            15,492            10,265
    Leasehold improvements                                                         6,196             6,196
    Accumulated depreciation                                                      (9,373)           (4,924)
                                                                             -----------       -----------
                                                                                  12,315            11,537
                                                                             -----------       -----------
Other assets:
    Security deposits                                                              7,596             7,596
                                                                             -----------       -----------
         Total assets                                                        $    89,148       $   125,641
                                                                             ===========       ===========
                      LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
    Accounts payable                                                         $   283,617       $    57,851
    Accrued expenses and other current liabilities                               276,726           376,992
    Deferred revenue                                                              19,323            12,068
    Notes payable to stockholders                                                377,500         2,177,500
    Notes payable                                                                 14,826         1,375,000
                                                                             -----------       -----------
         Total current liabilities                                               971,992         3,999,411
                                                                             -----------       -----------
Long-term liabilities
    Deferred revenue                                                              18,226            20,004
                                                                             -----------       -----------
         Total long-term liabilities                                              18,226            20,004
                                                                             -----------       -----------
         Total liabilities                                                       990,218         4,019,415
                                                                             -----------       -----------
    Stockholders' deficit:
       Preferred stock - no par value; 25,000,000 shares authorized; 1,682,044
        shares of Series A Zero Coupon issued and outstanding and 2,612,329
        shares of Series B Zero Coupon issued and
        outstanding at September 30, 2005                                      4,294,373              --
       Common stock - par value $.0005; 100,000,000 shares authorized;
        1,309,478 and 13,091,685 shares issued and outstanding at
        September 30, 2005 and December 31, 2004 respectively                        655             6,546
       Additional paid-in capital                                                677,559           671,668
       Accumulated deficit during development stage                           (5,873,657)       (4,571,988)
                                                                             -----------       -----------
          Total stockholders' deficit                                           (901,070)       (3,893,774)
                                                                             -----------       -----------
          Total liabilities and stockholders' deficit                        $    89,148       $   125,641
                                                                             ===========       ===========
</TABLE>

                       See Notes to Financial Statements.

                                       4
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
         FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2005 AND 2004
             FROM INCEPTION (October 2, 1989) to SEPTEMBER 30, 2005

<TABLE>
<CAPTION>
                                                       September 30, 2005                 September 30, 2004
                                                -------------------------------    ------------------------------          From
                                               For the Three     For the Nine      For the Three     For the Nine      Inception to
                                                Months Then       Months Then       Months Then       Months Then      September 30,
                                                   Ended             Ended             Ended            Ended              2005
                                                -----------       -----------       -----------       -----------       -----------
<S>                                             <C>               <C>               <C>               <C>               <C>
Revenues, net                                   $    63,547       $   112,858       $    20,417       $    31,310       $   188,626

Cost of revenues                                      8,612            29,492             1,187             2,542            38,654
                                                -----------       -----------       -----------       -----------       -----------
Gross profit                                         54,935            83,366            19,230            28,768           149,972
                                                -----------       -----------       -----------       -----------       -----------
Operating expenses:
    DVD production costs                             32,447           109,570            58,521           161,325           487,550
    General and administration                      171,950           586,417           232,629           847,508         2,976,603
    Sales and marketing                             160,410           351,437           123,443           361,539         1,522,138
    Depreciation and amortization                     1,663             4,449               855             2,409           153,930
                                                -----------       -----------       -----------       -----------       -----------
         Total operating expense                    366,470         1,051,873           415,448         1,372,781         5,140,221
                                                -----------       -----------       -----------       -----------       -----------
Operating loss                                     (311,535)         (968,507)         (396,218)       (1,344,013)       (4,990,249)
                                                -----------       -----------       -----------       -----------       -----------
Other income and (expense)
    Interest expense                                (29,294)         (334,367)         (134,681)         (303,028)         (891,431)
    Interest income                                     105               254              --                 438             1,686
    Other income                                       --                 951              --                --               2,512
    Gain on sale of subsidiary                         --                --                --               2,421
                                                -----------       -----------       -----------       -----------       -----------
         Total other income (expense)               (29,189)         (333,162)         (134,681)         (302,590)         (884,812)
                                                -----------       -----------       -----------       -----------       -----------
Loss before extraordinary items                    (340,724)       (1,301,669)         (530,899)       (1,646,603)       (5,875,061)

    Gain on extinguishment of debt                     --                --                --                --               1,404
                                                -----------       -----------       -----------       -----------       -----------
Loss before taxes                                  (340,724)       (1,301,669)         (530,899)       (1,646,603)       (5,873,657)

    Provision for income taxes                         --                --                --                --                --
                                                -----------       -----------       -----------       -----------       -----------

Net loss                                        $  (340,724)      $(1,301,669)      $  (530,899)      $(1,646,603)      $(5,873,657)
                                                ===========       ===========       ===========       ===========       ===========

Net loss per share, basic and diluted           $     (0.26)      $     (0.99)      $     (0.41)      $     (1.31)      $    (10.72)
                                                ===========       ===========       ===========       ===========       ===========

Weighted average shares, basic and diluted        1,309,478         1,309,337         1,309,169         1,259,904           547,904
                                                ===========       ===========       ===========       ===========       ===========
</TABLE>

                       See Notes to Financial Statements.

                                       5
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
            UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
     FOR PERIOD FROM INCEPTION (October 2, 1989) THROUGH SEPTEMBER 30, 2005


<TABLE>
<CAPTION>

                                                     Preferred Stock                     Common Stock                 Additional
                                              -----------------------------      ------------------------------        Paid-in
                                                 Shares          Amount              Shares           Amount           Capital
                                              ------------     ------------      ------------      ------------      ------------
<S>                                          <C>               <C>               <C>           <C>                 <C>
Issuance of $0.01 par value common
  shares to an individual for a note                  --               --        $      1,000      $        100      $      1,900
Payment of subscription receivable                    --               --                --                --                --
Stock split 2,000:1 and change par                    --               --                --                --                --
 value from $0.01 to $0.0005                          --               --           1,999,000               900              (900)
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 1996                            --               --           2,000,000             1,000             1,000

Repurchase of shares                                  --               --                --                --                --
Issuance of common stock                              --               --           2,476,000             1,238             3,762
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 1997                            --               --           4,476,000             2,238             4,762

Net loss                                              --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 1998                            --               --           4,476,000             2,238             4,762
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 1999                            --               --           4,476,000             2,238             4,762

Shares issued in connection
 with merger with Y2K Recording, Inc.                 --               --           1,025,000               513              --
Net income                                            --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 2000                            --               --           5,501,000             2,751             4,762

Shares issued in connection
 with merger with Savage Mojo, Inc.                   --               --           8,000,000             4,000              --
Shares issued for services                            --               --              10,000                 5               995
Contributed capital                                   --               --                --                --               5,672
Net loss                                              --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 2001                            --               --          13,511,000             6,756            11,429

Series A shares sold in private placement           47,750           95,500              --                --                --
Retire treasury stock                                 --               --          (1,725,000)             (863)           (4,137)
Shares issued as premium for notes                    --          2,939,553             1,470              --                --
Shares issued for Cohen employment
 agreement                                            --               --             748,447               374            74,471
Cancellation of outstanding stock
 returned by M. Klimes                                --               --          (4,000,000)           (2,000)             --
Shares issued for services                            --               --             312,000               156            31,044
Payment of subscription receivable                    --               --                --                --                --
Write off of subscription receivable
Net loss                                              --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 2002                          47,750           95,500        11,786,000             5,893           112,807

Shares issued for services                            --               --              50,000                25             4,975
Series A shares sold in private placement           53,500          107,000              --                --                --
Series B shares sold in private placement            1,000            2,000              --                --                --
Net loss                                              --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 2003                         102,250          204,500        11,836,000             5,918           117,782

Conversion of Series A to common                  (101,250)         525,959               263           202,237              --
Cancellation and refund of Series B                 (1,000)          (2,000)             --                --                --
Shares issued for services                            --               --             372,583               186           101,828
Shares issued for debt                                --               --             357,143               179           249,821
Net loss                                              --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, December 31, 2004                            --               --          13,091,685             6,546           671,668

Effects of 30: 1 reverse stock split                  --               --         (12,654,986)           (6,327)            6,327
Issuance of dividend shares                           --               --             872,779               436              (436)
Conversion of debt to preferred                  4,294,373        4,294,373
Net loss                                              --               --                --                --                --
                                              ------------     ------------      ------------      ------------      ------------

Balance, September 30, 2005                      4,294,373     $  4,294,373         1,309,478      $        655      $    677,559
                                              ============     ============      ============      ============      ============
</TABLE>

<TABLE>
                                                             Accumulated
                                                           Deficit during              Treasury Stock
                                           Subscription      Development       ------------------------------
                                            Receivable          Stage             Shares            Amount             Total
                                           ------------      ------------      ------------      ------------      ------------
<S>                                        <C>               <C>               <C>               <C>               <C>
Issuance of $0.01 par value common
  shares to an individual for a note       $     (2,000)     $       --        $       --        $       --        $       --
Payment of subscription receivable                1,885              --                --                --               1,885
Stock split 2,000:1 and change par                 --                --                --                --                --
 value from $0.01 to $0.0005                       --                --                --                --                --
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 1996                         (115)             --                --                --               1,885

Repurchase of shares                               --                --          (1,725,000)           (5,000)           (5,000)
Issuance of common stock                         (5,000)             --                --                --                --
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 1997                       (5,115)             --          (1,725,000)           (5,000)           (3,115)

Net loss                                           --              (2,867)             --              (2,867)             --
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 1998                       (5,115)           (2,867)       (1,725,000)           (5,000)           (5,982)
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 1999                       (5,115)           (2,867)       (1,725,000)           (5,000)           (5,982)

Shares issued in connection
 with merger with Y2K Recording, Inc.              --                --                --                 513
Net income                                         --                 434              --                --                 434
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 2000                       (5,115)           (2,433)       (1,725,000)           (5,000)           (5,035)

Shares issued in connection
 with merger with Savage Mojo, Inc.                --                --                --                --               4,000
Shares issued for services                         --                --                --                --               1,000
Contributed capital                                --                --                --                --               5,672
Net loss                                           --             (57,151)             --                --             (57,151)
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 2001                       (5,115)          (59,584)       (1,725,000)           (5,000)          (51,514)

Series A shares sold in private placement          --                --                --                --              95,500
Retire treasury stock                              --                --           1,725,000             5,000              --
Shares issued as premium for notes                 --                --                --                --               1,470
Shares issued for Cohen employment
 agreement                                         --                --                --                --              74,845
Cancellation of outstanding stock
 returned by M. Klimes                             --                --                --                --              (2,000)
Shares issued for services                         --                --                --                --              31,200
Payment of subscription receivable                5,000              --                --                --               5,000
Write off of subscription receivable                115                                                                     115
Net loss                                           --            (498,888)             --                --            (498,888)
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 2002                         --            (558,472)             --                --            (344,272)

Shares issued for services                         --                --                --                --               5,000
Series A shares sold in private placement          --                --                --                --             107,000
Series B shares sold in private placement          --                --                --                --               2,000
Net loss                                           --          (1,825,313)             --                --          (1,825,313)
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 2003                         --          (2,383,785)             --                --          (2,055,585)

Conversion of Series A to common                   --                --                --                --
Cancellation and refund of Series B                --                --                --                --              (2,000)
Shares issued for services                         --                --                --                --             102,014
Shares issued for debt                             --                --                --                --             250,000
Net loss                                           --          (2,188,203)             --                --          (2,188,203)
                                           ------------      ------------      ------------      ------------      ------------

Balance, December 31, 2004                         --          (4,571,988)             --                --          (3,893,774)

Effects of 30: 1 reverse stock split               --                --                --                --                --
Issuance of dividend shares                        --                --                --                --                --
Conversion of debt to preferred
Net loss                                           --          (1,301,669)             --                --          (1,301,669)
                                           ------------      ------------      ------------      ------------      ------------

Balance, September 30, 2005                $       --        $ (5,873,657)     $       --        $       --        $ (5,195,443)
                                           ============      ============      ============      ============      ============
</TABLE>

                       See Notes to Financial Statements.

                                       6

<PAGE>
                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
              FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2005 AND 2004
             FROM INCEPTION (October 2, 1989) to SEPTEMBER 30, 2005


<TABLE>
<CAPTION>
                                                                           Nine Months Ended                From
                                                                      ----------------------------      Inception to
                                                                     September 30,    September 30,     September 30,
                                                                         2005              2004             2005
                                                                      -----------      -----------      -----------
CASH FLOWS FROM OPERATING ACTIVITES
<S>                                                                   <C>              <C>              <C>
  Net loss                                                            $(1,301,669)     $(1,646,603)     $(5,873,657)
     Adjustments to reconcile net loss to net cash flows from operating
        activities:
          Depreciation and amortization expense                             4,449            2,409           17,004
          Gain on sale of subsidiary                                         --               --             (2,421)
          Gain on extinguishment of debt                                     --               --             (1,404)
          Compensation expense - stock for services                          --             (5,655)         106,045
          Bad debt expense                                                (10,000)            --                115
          Changes in assets and liabilities:
             Accounts receivable                                           19,470          (10,250)            --
             Other current receivables                                     (8,714)          28,819           (9,448)
             Prepaid expenses                                              34,233         (185,115)         (43,278)
             Security deposits                                               --               --             (7,596)
             Accounts payable                                             218,200          (75,168)         276,051
             Accrued expenses and other current liabilities               546,976          (90,650)         964,469
                                                                      -----------      -----------      -----------

Net cash flows (used) in operating activities                            (497,055)      (1,982,213)      (4,574,120)
                                                                      -----------      -----------      -----------

CASH FLOWS FROM INVESTING ACTIVITIES
  Purchase of equipment                                                    (5,227)          (5,645)         (22,188)
                                                                      -----------      -----------      -----------

Net cash flows (used) in investing activities                              (5,227)          (5,645)         (22,188)
                                                                      -----------      -----------      -----------

CASH FLOWS FROM FINANCING ACTIVITIES
  Common stock issued                                                        --               --             14,185
  Common stock issued for debt                                               --            329,396          250,000
  Common stock issued for services                                           --             22,619          102,014
  Common stock subscriptions (issued) paid                                   --               --               (115)
  Preferred stock issued                                                4,294,373             --          4,496,873
  Repurchase of preferred stock                                            (2,000)            --                 --
  Proceeds from notes payable                                             500,000        2,000,000        1,875,000
  Repayment of notes payable                                           (1,682,044)         (28,500)      (1,682,044)
  Repayment of loans from stockholders                                 (2,612,329)         (50,000)        (443,094)
  Decrease in bank overdraft                                               (8,204)              --               --
                                                                      -----------      -----------      -----------

Net cash flows provided by financing activities                           500,000        2,263,311        4,612,819
                                                                      -----------      -----------      -----------

Decrease in cash                                                           (2,282)         275,453           16,511
Cash, beginning of period                                                  18,793             --               --
                                                                      -----------      -----------      -----------
Cash, end of period                                                   $    16,511      $   275,453      $    16,511
                                                                      ===========      ===========      ===========
               SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest                                                $     1,224      $     2,739      $     6,740
                                                                      ===========      ===========      ===========
</TABLE>


                       See Notes to Financial Statements.

                                       7

<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Medical Media Television, Inc. ("Medical Media" or the "Company"; references to
"we," "our" or "us" also mean the Company) was organized as a Florida
corporation on October 2, 1989.

A Written Action of a Majority of the Shareholders in Lieu of Special Meeting
was signed on April 6, 2005, in which 7,079,471 shares of the total shares of
the Common Stock outstanding of 13,091,685 (54.07%) approved a Memorandum of
Terms for the Company's acquisition of African American Medical Network, Inc.
("African American Medical Network"), a wholly-owned subsidiary of AFMN, Inc., a
Delaware corporation, and authorized the Company's Board of Directors to (i)
change the Company's corporate name from PetCARE Television Network, Inc. to
Medical Media Television, Inc.; (ii) combine the Company's issued and
outstanding Common Stock on a 1:30 basis effective as of May 4, 2005; and (iii)
declare and issue a dividend of two (2) shares of the Company's restricted
Common Stock for each share of Common Stock held by shareholders of record as of
May 10, 2005. On April 21, 2005, PetCARE Television Network, Inc. changed its
name to Medical Media Television, Inc. On April 22, 2005, Medical Media
organized a wholly-owned subsidiary, PetCARE Television Network, Inc., a Florida
corporation ("PetCARE TV"). Also on April 22, 2005, Medical Media organized AAMN
Acquisition Sub, Inc. a wholly-owned Florida corporation, for the purpose of
acquiring African American Medical Network.

On July 14, 2005, the Board of Directors of the Company approved the
Certificates of Designations, Preferences, Rights and Limitations for the Series
A Zero Coupon Preferred Stock and Series B Zero Coupon Preferred Stock, and the
Company filed an amendment to its Articles of Incorporation which designated
1,682,044 shares of the authorized and unissued Preferred Stock of the Company
as Series A Zero Coupon Preferred Stock and 2,612,329 shares of the authorized
and unissued Preferred Stock of the Company as Series B Zero Coupon Preferred
Stock. Also on July 14, 2005, the Company retired the entire class of Series B
Convertible Preferred Stock to the status of authorized but unissued and
undesignated shares of Preferred Stock of the Company.

Medical Media is a development stage company, and as such has devoted its
efforts since inception to developing and implementing its business plan, which
includes but is not limited to establishing a subscriber network of
approximately 3,000 veterinary clinics and hospitals, writing and producing its
monthly DVD magazines, making contacts with potential advertisers, obtaining
debt and equity financing, establishing its accounting systems, and performing
other administrative functions. Medical Media's goal is to be recognized as a
leading provider of advertiser-supported patient/client medical education
programming within the place-based media environment of medical specialty
offices nationwide.

Medical Media, through its wholly-owned subsidiary PetCARE TV, provides
educational programming, targeted to pet owners, focused on optimal healthcare
for animal companions. Programming is obtained through a one or three-year
subscription, with a TV/DVD system included in the three-year plan. Updated DVD
magazines are shipped monthly to all veterinarian subscribers and are funded, in
part, by commercial advertisers whose commercials are presented on the DVD
magazines.

Basis of Accounting

Medical Media maintains its financial records and financial statements on the
accrual basis of accounting. The accrual basis of accounting provides for a
better matching of revenues and expenses.

                                       8
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Interim Information

The accompanying unaudited financial statements of Medical Media have been
prepared in accordance with accounting principles generally accepted in the
United States of America for interim financial information and with the
instructions to Form 10-QSB and Rule 10-01 of Regulation S-X. All adjustments,
which in the opinion of management are necessary for a fair presentation of the
financial condition and results of operations, have been included. Operating
results for the three and nine-month period ended September 30, 2005 are not
necessarily indicative of the results that may be expected for the year ending
December 31, 2005.

Cash and Cash Equivalents

For purposes of the Statements of Cash Flows, Medical Media considers amounts
held by financial institutions and short-term investments with an original
maturity of 90 days or less to be cash and cash equivalents.

Fiscal Year

Medical Media elected December 31 as its fiscal year.

Revenue Recognition

The Company generates revenue from two primary sources, namely advertisers on
PetCARE TV's DVD magazines (the "Advertisers") and subscribers to its PetCARE TV
network (the "Subscribers"). With regard to Advertisers, revenue is recognized
over the periods in which the advertisers' commercials appear on the DVD
magazine. With regard to Subscribers, revenue is recognized proportionately over
the length of the subscription agreement entered into by the Subscribers.

Income Taxes

Medical Media records its federal and state tax liability in accordance with
Financial Accounting Standards Board Statement No. 109 "Accounting for Income
Taxes". The deferred taxes payable are recorded for temporary differences
between the recognition of income and expenses for tax and financial reporting
purposes, using current tax rates. Deferred assets and liabilities represent the
future tax consequences of those differences, which will either be taxable or
deductible when the assets and liabilities are recovered or settled.

Since its inception, Medical Media has an accumulated loss of $5,873,657 for
income tax purposes, which can be used to offset future taxable income through
2023. The potential tax benefit of this loss is as follows:

                  Future tax benefit                   $  1,762,097
                  Valuation allowance                    (1,762,097)
                                                       ------------

                  Future tax benefit                   $       --
                                                       ============

As of September 30, 2005, no deferred taxes were recorded in the accompanying
financial statements.

                                       9
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Advertising Costs

Medical Media expenses the production costs of advertising the first time the
advertising takes place.

Fixed Assets

Medical Media's fixed assets consist of computer equipment being depreciated
over 3 years and leasehold improvements being depreciated over the remaining
life of the current lease.

Going Concern

Medical Media Television, Inc., f/k/a PetCARE Television Network, Inc., was
organized as a Florida corporation on October 2, 1989 and is a development stage
company, and as such, has devoted its efforts since inception to developing and
implementing its business plan. Realization of a major portion of the assets is
dependent upon the Company's ability to meet its future financing requirements
and the success of future operations.

Use of Estimates

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.

NOTE B - COMMON AND PREFERRED STOCK

COMMON STOCK

Start of trading on the OTC Bulletin Board

On February 2, 2004, Medical Media's Common Stock began trading on the
OTC-Bulletin Board under the symbol PTNW. As a result of the Company's corporate
name change to Medical Media Television, Inc., the Company's Common Stock is now
traded under the symbol of MMTV. There is a limited public trading market for
its Common Stock and a regular, more active trading market may not develop, or
if developed, may not be sustained.

Combination of Common Stock

A Written Action of a Majority of the Shareholders in Lieu of Special Meeting
was signed on April 6, 2005, in which 7,079,471 shares of the total shares of
the Common Stock outstanding of 13,091,685 (54.07%) authorized the Company's
Board of Directors to combine the Company's issued and outstanding Common Stock
on a 1:30 basis effective as of May 4, 2005.


                                       10
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Issuance of Common Stock

On February 13, 2004, Medical Media entered into a Note Purchase Agreement with
Victus Capital, LP, a Delaware limited partnership ("Victus") and issued Victus
a Subordinated Convertible Promissory Note (the "Victus February Note"). Under
the terms of the Victus February Note, Victus loaned us $1,000,000 with interest
of $62,500 per quarter. In order to insure that interest payments were made,
$250,000 of the principal amount of the Victus February Note was delivered to an
escrow agent to be held for the purposes of making quarterly interest payments
to Victus. In May 2004, Medical Media issued 357,143 (11,905 post-split) shares
of its Common Stock at $.70 ($2.10 post-split) per share and 714,286 (23,810
post-split) Common Stock Purchase Warrants ("Victus February Warrants") in lieu
of $250,000 in interest due on the Victus February Note. Accordingly, the
$250,000 being held in escrow was released to the Company in exchange for the
shares and the Victus February Warrants. Each Victus February Warrant is
exercisable into the Company's Common Stock at $1.00 ($30.00 post-split) per
share at any time for five years from the date of issuance. On September 1,
2005, the Company reduced the exercise price of these warrants to $2.40. The
Victus February Note, the shares of Common Stock, and Victus February Warrants
were issued under the exemption from registration provided in Section 4(2) of
the Securities Act of 1933 (the "Securities Act"). In March 2005, Vicis Capital
Master Fund, a fund managed by Vicis Capital, LP, a Delaware limited partnership
("Vicis Capital") acquired certain assets of Victus. Included in the acquisition
were the Victus February Note, the shares of the Company's Common Stock, and the
Victus February Warrants discussed above. Pursuant to the terms of a Debt
Exchange Agreement dated July 8, 2005 between Vicis Capital and the Company, the
Victus February Note was converted into 1,100,000 shares of the Company's Series
B Zero Coupon Preferred Stock and 825,000 five-year Warrants to purchase shares
of Common Stock of Medical Media ("Vicis Capital Debt Exchange Warrants") at an
exercise price of fifteen cents ($.15).

In April 2004, Medical Media issued 67,583 shares of Common Stock (2,253 shares
of "post-combination" Common Stock) to two vendors in exchange for debt recorded
as accounts payable on the accompanying financial statements. The shares of
Common Stock were issued under the exemption from registration provided in
Section 4(2) of the Securities Act.

In May 2004, Medical Media issued Common Stock purchase warrants to H. C.
Wainwright, Inc. and its assigns, to purchase 533,333 (17,780 post-split) shares
of the Company's Common Stock at an exercise price of $0.375 ($11.25 post-split)
per share with a term of five years. These warrants were issued as fees due as a
result of funds raised in a private transaction. On September 1, 2005, the
Company reduced the exercise price of these warrants to $2.40 per share. The
Wainwright Warrants were issued under the exemption from registration provided
in Section 4(2) of the Securities Act.

In June 2004, the Company issued 250,000 shares of Common Stock (8,333 shares of
"post-combination" Common Stock) to a vendor in exchange for debt. The shares of
Common Stock were issued under the exemption from registration provided in
Section 4(2) of the Securities Act.

                                       11
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE B - COMMON AND PREFERRED STOCK (Continued)

During the three months ended June 30 2004, the Company issued an aggregate of
55,000 shares of Common Stock (1,833 shares of "post-combination" Common Stock)
to members of its Veterinary Advisory Board.

On July 28, 2004, the Company entered into a seven-month financial consulting
agreement with TotalCFO, Inc. ("TotalCFO"). In connection therewith, Medical
Media issued Common Stock purchase warrants to TotalCFO, LLC to purchase 300,000
(10,000 post-split) shares of the Company's Common Stock at an exercise price of
$0.75 ($22.50 post-split) per share with a term of five years. On September 1,
2005, the Company reduced the exercise price of these warrants to $2.40. These
warrants were issued as fees as a result of funds raised in a private placement
transaction. The TotalCFO Warrants were issued in September 2004 under the
exemption from registration provided in Section 4(2) of the Securities Act.

On May 10, 2005, the Company issued a dividend of two (2) shares of the
Company's restricted Common Stock for each share of Common Stock held by
shareholders of record as of May 10, 2005 with the payment date being May 17,
2005.

Stock Options

We have an equity incentive plan available to key employees and consultants of
the Company. Under the plan, we may grant options for up to 66,667 post-split
shares of Common Stock. The exercise price of each incentive option is equal to
the greater of the fair market value of our Common Stock on the date of grant or
the aggregate par value of the stock on the date of grant. In the case of any
10% stockholder, the incentive option price will not be less than 110% of the
fair market value on the date of grant. The Compensation Committee of the Board
of Directors shall determine the price at which shares of stock may be purchased
under a nonqualified option. Options expire ten years from the date of grant,
except for those granted to a 10% stockholder, which expire five years from the
date of grant. To date, we have granted 5,300 post-split options under this
equity incentive plan.

PREFERRED STOCK

Series B Convertible Preferred Stock

On October 21, 2003, the Company's Board of Directors approved the Certificate
of Designation, Preferences, Rights and Limitations for Series B Convertible
Preferred Stock ("Series B Preferred Stock") for 1,000,000 shares with no par
value per share. In November 2003, Medical Media offered the 1,000,000 shares of
Series B Preferred Stock in a private placement for $2.00 per unit consisting of
one share of Series B Preferred Stock and one Common Stock Purchase Warrant.
After only selling 1,000 units for $2,000 to a single shareholder, the Company
decided to discontinue the offering and refunded the $2,000. The offering is
claimed to be exempt under Section 4(2) of the Securities Act.

On May 18, 2004, the Board of Directors of Medical Media approved an amendment
to the Certificate of Designation, Preferences, Rights and Limitations for
Series B Convertible Preferred Stock ("Series B Preferred Stock") increasing the
number of authorized shares to 1,500,000. These shares of Series B Preferred
Stock were convertible into the Company's Common Stock at any time commencing
one (1) year from the date of issuance at a variable conversion price equal to
70% of the average closing price as reported by Bloomberg L.P. for the 20
trading days preceding the date of conversion. However, in no event

                                       12
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE B - COMMON AND PREFERRED STOCK (Continued)

would the conversion price be less than $0.50 per share, nor greater than $1.50
per share. The holders of the Series B Preferred Stock were entitled to
dividends of 8% per annum, payable in one payment upon conversion of the Series
B Preferred Stock. In June 2004, Medical Media offered the 1,500,000 shares of
its Series B Preferred Stock in a private placement for $1.00 per unit
consisting of one share of Series B Preferred Stock and one Common Stock
Purchase Warrant. The offering is claimed to be exempt under Section 4(2) of the
Securities Act. No units were sold under this offering and on July 14, 2005 the
Company's Board of Directors approved an amendment to cancel the preferences for
the Series B Preferred Stock, returning the 1,500,000 shares to undesignated and
unissued shares of Preferred Stock.

Zero Coupon Preferred Stock

The Board of Directors of Medical Media approved the Certificates of
Designations, Preferences, Rights and Limitations for Series A Zero Coupon
Preferred Stock and Series B Zero Coupon Preferred Stock. The Company filed an
amendment to its articles of incorporation on July 14, 2005, which authorized
1,682,044 shares of Series A Zero Coupon Preferred Stock with $1.00 Stated Value
and 2,612,329 shares of Series B Zero Coupon Preferred Stock with $1.00 Stated
Value. Both series of preferred shares are convertible into the Company's Common
Stock at the option of the holder any time after the date of issuance at the
rate of $2.40 and $3.00 respectively per share. The holders of the Series A Zero
Coupon Preferred Stock and Series B Zero Coupon Preferred Stock will be entitled
to receive, when and as declared by the Board of Directors, if at all, dividends
on parity with each holder of one or more shares of the Common Stock. Any
dividend or other distribution meeting these requirements will be payable in an
amount equal to the product of (a) the dividend payable on each share of Common
Stock and (b) the number of shares of Common Stock issuable upon conversion of a
share of Series A Zero Coupon Preferred Stock and Series B Zero Coupon Preferred
Stock, in each case, calculated on the record date for determination of holders
entitled to receive such dividend.

Series A Zero Coupon Preferred Stock

The Company's Series A Zero Coupon Preferred Stock is non-voting capital stock
and has a stated value of $1.00 per share and is convertible into the Company's
Common Stock at the option of the holder any time after the date of issuance at
the initial rate of $2.40 per share. The holders of the Series A Zero Coupon
Preferred Stock will be entitled to receive, when and if declared by the Board
of Directors, dividends on parity with holders of the Company's Common Stock.
Any dividend or other distribution meeting these requirements will be payable in
an amount equal to the product of (a) the dividend payable on each share of
Common Stock and (b) the number of shares of Common Stock issuable upon
conversion of a share of Series A Zero Coupon Preferred Stock, calculated on the
record date for determination of holders entitled to receive such dividend. In
addition, in the event of any voluntary or involuntary liquidation, dissolution,
or winding up of the Company, the holders of shares of Series A Zero Coupon
Preferred Stock are entitled to be paid out of the assets available for
distribution before any payment shall be made to the holders of Common Stock or
any other class or series of stock ranking on liquidation junior to the Series A
Zero Coupon Preferred Stock, an amount equal to One Million Three Hundred
Seventy Five Thousand and No/100 Dollars ($1,375,000). The holders of Series A
Zero Coupon Preferred Stock also have preemptive rights to purchase any equity
securities, debt securities possessing rights, preferences, privileges and
limitations similar to equity securities, or rights, options, warrants or
convertible or exchangeable securities containing the right to subscribe for or
purchase shares of equity securities of the Company at the price and on the
terms and conditions the Company is offering them.

                                       13
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE B - COMMON AND PREFERRED STOCK (Continued)

Series B Zero Coupon Preferred Stock

The Company's Series B Zero Coupon Preferred Stock is non-voting capital stock
and has a stated value of $1.00 per share and is convertible into the Company's
Common Stock at the option of the holder any time after the date of issuance at
the initial rate of $3.00 per share. The holders of the Series B Zero Coupon
Preferred Stock will be entitled to receive, when and if declared by the Board
of Directors, dividends on parity with holders of the Company's Common Stock.
Any dividend or other distribution meeting these requirements will be payable in
an amount equal to the product of (a) the dividend payable on each share of
Common Stock and (b) the number of shares of Common Stock issuable upon
conversion of a share of Series B Zero Coupon Preferred Stock, calculated on the
record date for determination of holders entitled to receive such dividend. In
addition, in the event of any voluntary or involuntary liquidation, dissolution,
or winding up of the Company, the holders of shares of Series B Zero Coupon
Preferred Stock are entitled to be paid out of the assets available for
distribution after taking into account the Series A Zero Coupon Preferred Stock
liquidation preference, but before any payment shall be made to the holders of
Common Stock or any other class or series of stock ranking on liquidation junior
to the Series B Zero Coupon Preferred Stock, an amount equal to Two Million
Three Hundred Thousand and No/100 Dollars ($2,300,000).

NOTE C - RELATED PARTY TRANSACTIONS

On June 1, 2002, we entered into a consulting agreement with James Calaway, a
shareholder and former director of the Company under which we will pay him $667
per month until we have received $2.5 million in equity funding. As of June 30,
2005, we had received $204,500 in equity funding. Management believes the
Company will receive the remainder of the $2.5 million in funding within the
next twelve months.

In May and June 2002, the Company issued non-interest bearing promissory notes
to the following shareholders:

      o     James Calaway in the original principal amount of $100,000; current
            balance $91,500
      o     Daniel V. Hugo, a former officer/director, in the original principal
            amount of $25,000; current balance $25,000
      o     Robert and Janna Hugo in the original principal amount of $6,000;
            current balance $6,000
      o     Robert and Jamie Turner in the original principal amount of $5,000;
            current balance $5,000

The repayment of these notes is contingent upon the receipt of funds received
through private placement transactions pursuant to Rule 506, with periodic
payments to be made to the holders as follows: 10% due after the first $300,000
is received; 10% due after the next $100,000 is received; 10% due after the next
$100,000 is received, 35% due after the next $100,000 is received; and the
remaining 35% due after the next $100,000 is received. As of December 31, 2004
and September 30, 2005, the aggregate principal balance on these notes was
$127,500.

                                       14
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE C - RELATED PARTY TRANSACTIONS (Continued)

On March 10, 2003, May 28, 2003, June 6, 2003, and July 1, 2003 we entered into
Note Purchase and Security Agreement(s) and Senior Convertible Promissory
Note(s) (the "Edge Notes") with Pet Edge, LLC, a Connecticut limited liability
company ("Edge"). Edge was organized for the sole purpose of funding our
business plan. Under the terms of the Edge Notes, Edge loaned us $1,000,000,
$50,000, $50,000, and $275,000 respectively with simple interest at the rate of
ten percent (10%) per annum. All principal and accrued interest on the Edge
Notes was due March 9, 2006, May 27, 2006, June 5, 2006, and June 30, 2006
respectively. The Edge Notes could not be prepaid in whole or in part without
the written consent of Edge. To secure our obligations under the Edge Notes, we
granted Edge a first priority security interest in all of our assets, owned as
of the date of the Edge Notes and acquired during the term of the Edge Notes.
The principal and interest on the Edge Notes was convertible into pre-split
shares of our Common Stock at $.246 per share. On November 10, 2003, we entered
into an agreement with Edge to amend the terms of conversion of the Edge Notes
(the "Edge Amendment"). Pursuant to the terms of the Debt Exchange Agreement
dated July 8, 2005 by and between Edge and the Company ("Edge Debt Exchange
Agreement") the Edge Notes were converted into 1,682,044 shares of the Company's
Series A Zero Coupon Preferred Stock and 2,102,556 five-year Warrants to
purchase shares of Common Stock of Medical Media ("Edge Debt Exchange Warrants")
at an exercise price of fifteen cents ($.15).

On June 10, 2003, we entered into a Note Purchase Agreement and Convertible
Promissory Note with a former director, Mark Maltzer (the "Maltzer Note"). Under
the terms of the Maltzer Note, Dr. Maltzer agreed to loan us $50,000 with simple
interest at a rate of ten percent (10%) per annum. All principal and accrued
interest was due June 9, 2006. The principal and interest on the Maltzer Note
was convertible into pre-split shares of Common Stock of the Company at $.246
per share. Pursuant to the terms of the Debt Exchange Agreement dated July 8,
2005 by and between Dr. Maltzer and the Company ("Maltzer Debt Exchange
Agreement") the Maltzer Note was converted into 60,411 shares of the Company's
Series B Zero Coupon Preferred Stock and 45,308 five-year Warrants to purchase
shares of Common Stock of Medical Media ("Maltzer Debt Exchange Warrants) at an
exercise price of fifteen cents ($.15).

NOTE D - COMMITMENTS AND CONTINGENCIES

On June 5, 2002, we entered into an employment agreement with Philip Cohen that
has an infinite term. This agreement automatically renews every ninety days
commencing June 5, 2002. We may terminate the agreement with cause, effective
upon delivery of written notice to Mr. Cohen, except where the cause is a
material breach of the agreement, Mr. Cohen has sixty days to cure the material
breach after receiving written notice from us. We may terminate this agreement
without cause, effective sixty days after delivery of written notice to Mr.
Cohen. Mr. Cohen may terminate this agreement with cause provided he delivers
written notice to us sixty days before termination, or without cause provided he
delivers written notice one year before termination. If we terminate the
agreement without cause, or Mr. Cohen terminates the agreement with cause, we
will be obligated to pay Mr. Cohen the compensation, remuneration and expenses
specified below for a period of five years from the date of notice. Under the
terms of the agreement, Mr. Cohen will receive an annual salary of $150,000,
payable in monthly installments of $12,500. This salary will be renegotiated at
the end of each fiscal year. The salary was not renegotiated at the end of
fiscal year 2002, 2003, or 2004. Mr. Cohen will also receive medical and
long-term disability insurance at our expense, as well as an automobile for
business use, and reimbursement for certain business expenses. The agreement
requires that Mr. Cohen devote such time and attention to our business and
affairs as is reasonably necessary to carry out his duties; provided, however,
that he must devote no less than forty hours per week to his duties for us.

                                       15
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE D - COMMITMENTS AND CONTINGENCIES (Continued)

On August 19, 2003, Medical Media entered into a sixty-two (62) month lease
agreement commencing on October 1, 2003 with Liberty Property Limited
Partnership for approximately 3,800 square feet of office/warehouse space
located at 8406 Benjamin Road, Suite C, Tampa, Florida 33634. Lease expense for
2004 totaled $38,593. Under this agreement, projected lease expense for the 12
months ended December 31, 2005 through 2007 and the eleven months ended November
30, 2008 will be approximately $39,400, $40,300, $41,100 and $38,500
respectively.

NOTE E - DEBT EXCHANGE AGREEMENT

Debt Exchange Agreement (Series A Zero Coupon Preferred Stock)

On July 8, 2005, the Company entered into a Debt Exchange Agreement with Edge
whereby Edge agreed to cancel the Edge Notes in exchange for 1,682,044 shares of
the Company's Series A Zero Coupon Preferred Stock (described below) and
2,102,556 Edge Debt Exchange Warrants (described below). Pursuant to the Edge
Debt Exchange Agreement, the Edge Notes were cancelled and (a) the obligations
of the Company to pay the principal of, interest on or redemption premium on the
Edge Notes terminated; (b) the obligations of the Company to pay any interest
remaining unpaid in respect of the Edge Notes terminated; (c) all obligations of
Edge pursuant to the Edge Notes terminated; and (d) all obligations of the
Company in respect of the cancelled Edge Notes terminated. The Company also
agreed to file, at its sole cost and expense, a Form S-4 no later than
forty-five (45) days after the closing registering (a) all shares of Common
Stock issuable upon conversion of the Series A Zero Coupon Preferred Stock, and
(b) all shares of Common Stock issuable upon exercise of the Edge Debt Exchange
Warrants. The Company agreed to use its best efforts to have the Form S-4
declared effective within one hundred twenty (120) days after closing. The
Series A Zero Coupon Preferred Stock and the Edge Debt Exchange Warrants were
issued pursuant to the exemption from registration found in Section 3(a)(9) of
the Securities Act of 1933.

Debt Exchange Agreement (Series B Zero Coupon Preferred Stock)

On July 8, 2005, the Company entered into a Debt Exchange Agreement with Vicis
Capital whereby Vicis Capital agreed to cancel the Victus February Note, Victus
July Note and the Series A Debentures (collectively, the "Vicis Capital Notes")
in exchange for 2,551,918 shares of Series B Zero Coupon Preferred Stock
(described below) and 1,913,939 Vicis Capital Debt Exchange Warrants (described
below). Pursuant to the Vicis Capital Debt Exchange Agreement, the Vicis Capital
Notes were cancelled and (a) the obligations of the Company to pay the principal
of, interest on or redemption premium on the Vicis Capital Notes terminated; (b)
the obligations of the Company to pay any interest remaining unpaid in respect
of the Vicis Capital Notes terminated; (c) all obligations of Vicis Capital
pursuant to the Vicis Capital Notes terminated; and (d) all obligations of the
Company in respect of the cancelled Vicis Capital Notes terminated.

Also on July 8, 2005, the Company entered into a Debt Exchange Agreement with
Maltzer whereby Maltzer agreed to tender the Maltzer Note in exchange for 60,411
shares of the Company's Series B Zero Coupon Preferred Stock and 45,308 Maltzer
Debt Exchange Warrants (described below). Pursuant to the Maltzer Debt Exchange
Agreement, the Maltzer Note was cancelled and (a) the obligations of the

                                       16
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE E - DEBT EXCHANGE AGREEMENT (Continued)

Company to pay the principal of, interest on or redemption premium on the
Maltzer Note terminated; (b) the obligations of the Company to pay any interest
remaining unpaid in respect of the Maltzer Note terminated; (c) all obligations
of Maltzer pursuant to the Maltzer Note terminated; and (d) all obligations of
the Company in respect of the cancelled Maltzer Note terminated.

The Series B Zero Coupon Preferred Stock, the Vicis Capital Debt Exchange
Warrants and the Maltzer Debt Exchange Warrants were issued pursuant to the
exemption from registration found in Section 3(a)(9) of the Securities Act of
1933.

NOTE F - SUBORDINATED CONVERTIBLE PROMISSORY NOTES

On February 13, 2004, Medical Media entered into a Note Purchase Agreement with
Victus Capital, LP, a Delaware limited partnership ("Victus") and issued Victus
a Subordinated Convertible Promissory Note (the "Victus February Note"). Under
the terms of the Victus February Note, Victus loaned us $1,000,000 with interest
of $62,500 per quarter. In order to insure that interest payments were made,
$250,000 of the principal amount of the Victus February Note was delivered to an
escrow agent to be held for the purposes of making quarterly interest payments
to Victus. In May 2004, Medical Media issued 357,143 (11,905 post-split) shares
of its Common Stock at $.70 ($2.10 post-split) per share and 714,286 (23,810
post-split) Common Stock Purchase Warrants ("Victus February Warrants") in lieu
of $250,000 in interest due on the Victus February Note. Accordingly, the
$250,000 being held in escrow was released to the Company in exchange for the
shares and the Victus February Warrants. Each Victus February Warrant is
exercisable into the Company's Common Stock at $1.00 ($30.00 post-split) per
share at any time for five years from the date of issuance. On September 1,
2005, the Company reduced the exercise price of these warrants to $2.40. The
Victus February Note, the shares of Common Stock, and Victus February Warrants
were issued under the exemption from registration provided in Section 4(2) of
the Securities Act of 1933 (the "Securities Act"). In March 2005, Vicis Capital
Master Fund, a fund managed by Vicis Capital, LP, a Delaware limited partnership
("Vicis Capital") acquired certain assets of Victus. Included in the acquisition
were the Victus February Note, the shares of the Company's Common Stock, and the
Victus February Warrants discussed above. Pursuant to the terms of a Debt
Exchange Agreement dated July 8, 2005 between Vicis Capital and the Company, the
Victus February Note was converted into 1,100,000 shares of the Company's Series
B Zero Coupon Preferred Stock and 825,000 five-year Warrants to purchase shares
of Common Stock of Medical Media ("Vicis Capital Debt Exchange Warrants") at an
exercise price of fifteen cents ($.15).

On July 27, 2004, Medical Media entered into a Note Purchase Agreement with
Victus Capital and issued a Subordinated Convertible Promissory Note ("Victus
July Note"), and Warrant to Purchase Shares of Common Stock (the "Victus July
Warrant"). Under the terms of the Victus July Note, Victus loaned us $1,000,000,
at an annual rate of interest of twenty percent (20%) compounded semi-annually.
The Victus July Note had a term of twelve months. On the date of maturity, the
Victus July Note was convertible, at the option of the holder, into shares of
our Common Stock at $.40 per share. Pursuant to the terms of the Victus July
Warrant, Victus may purchase up to 2,500,000 (83,333 post-split) shares of our
Common Stock at an exercise price of $0.75 ($22.50 post-split) per share until
the expiration date of July 26, 2009. On September 1, 2005, the Company reduced
the exercise price of these warrants to $2.40.The Victus July Note may not be
converted and the Victus July Warrant may not be exercised to the extent that
Victus'

                                       17
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE F - SUBORDINATED CONVERTIBLE PROMISSORY NOTES (Continued)

overall ownership of the Company's Common Stock exceeds 4.99%, unless such
limitation is waived by Victus upon no less than sixty-one days (61) advance
written notice. In March 2005, Vicis Capital acquired certain assets of Victus.
Included in the acquisition were the Victus July Note and the Victus July
Warrant discussed above. Pursuant to the terms of a Debt Exchange Agreement
dated July 8, 2005 between Vicis Capital and the Company, the Victus July Note
was converted into 1,189,589 shares of the Company's Series B Zero Coupon
Preferred Stock and 892,192 five-year Vicis Capital Debt Exchange Warrants to
purchase shares of Common Stock of Medical Media at an exercise price of fifteen
cents ($.15).

On March 11, 2005, the Company issued to Vicis Capital its Series A Convertible
Debentures ("Series A Debentures"), Series A Common Stock Purchase Warrants,
Series B Common Stock Purchase Warrants, and Series C Common Stock Purchase
Warrants pursuant to the exemption from registration found in Section 4(2) of
Regulation D under the Securities Act of 1933. Pursuant to the terms of the
Series A Debentures, Vicis Capital loaned the Company an aggregate of $250,000
at an annual rate of interest of fifteen percent (15%). The Series A Debentures
had a term of 24 months and the Company had the option to pay the interest
semi-annually in cash or in shares of its registered Common Stock at a ten
percent (10%) discount to the market price based on the average of the twenty
(20) trading days prior to the payment of the interest. On the date of maturity
of the Series A Debentures, Vicis Capital had the option to convert the Series A
Debentures into shares of the Company's Common Stock at a price of $0.10 ($3.00
post-split) per share. Under the terms of the Series A Common Stock Purchase
Warrants, Vicis Capital may purchase up to 2,500,000 (83,335 post-split) shares
of the Company's Common Stock at an exercise price of $0.10 ($3.00 post-split)
per share for a ten-year period. On September 1, 2005, the Company reduced the
exercise price of these warrants to $2.40. Under the terms of the Series B
Common Stock Purchase Warrants, Vicis Capital may purchase up to 2,500,000
(83,335 post-split) shares of the Company's Common Stock at an exercise price of
$0.125 ($3.75 post-split) per share for a five-year period. On September 1,
2005, the Company reduced the exercise price of these warrants to $2.40. Under
the terms of the Series C Common Stock Purchase Warrants, Vicis Capital may
purchase up to 1,250,000 (41,670 post-split) shares of the Company's Common
Stock at an exercise price of $.10 ($3.00 post-split) per share for a one-year
period. On September 1, 2005, the Company reduced the exercise price of these
warrants to $2.40. The Series A Debentures and Series A, B, and C Common Stock
Purchase Warrants may not be converted and exercised to the extent that Vicis
Capital's overall ownership of the Company's Common Stock exceeds 4.99%, unless
such limitation is waived by Vicis Capital upon no less than sixty-one days (61)
advance written notice. Pursuant to the terms of a Debt Exchange Agreement dated
July 8, 2005 between Vicis Capital and the Company, the Series A Debentures were
converted into 262,329 shares of the Company's Series B Zero Coupon Preferred
Stock and 196,747 five-year Vicis Capital Debt Exchange Warrants to purchase
shares of Common Stock of Medical Media at an exercise price of fifteen cents
($.15).

On May 6, 2005, the Company issued to Vicis Capital its Series B Convertible
Debenture ("Series B Convertible Debenture"), Series D Common Stock Purchase
Warrants, Series E Common Stock Purchase Warrants, and Series F Common Stock
Purchase Warrants pursuant to the exemption from registration found in Section
4(2) of Regulation D under the Securities Act of 1933. Pursuant to the terms of
the Series B Convertible Debenture, Vicis Capital loaned the Company an
aggregate of $250,000 at an annual rate of interest of fifteen percent (15%).
The Series B Convertible Debenture have a term of 24 months and the Company has
the option to pay the interest semi-annually in cash or in shares of its
registered Common Stock at a ten percent (10%) discount to the market price
based on the average five (5) days Volume Weighted Average Closing Price of the
Company's Common Stock for the five (5) trading days

                                       18
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE F - SUBORDINATED CONVERTIBLE PROMISSORY NOTES (Continued)

prior to payment. On the date of maturity of the Series B Convertible Debenture,
Vicis Capital has the option to convert the Series B Convertible Debenture into
post-split shares of the Company's Common Stock at a price of $2.40 per share.
Under the terms of the Series D Common Stock Purchase Warrants, Vicis Capital
may purchase up to 104,167 post-split shares of the Company's Common Stock at an
exercise price of $2.40 per share for a ten (10) year period. Under the terms of
the Series E Common Stock Purchase Warrants, Vicis Capital may purchase up to
104,167 post-split shares of the Company's Common Stock at an exercise price of
$2.40 per share for a five (5) year period. Under the terms of the Series F
Common Stock Purchase Warrants, Vicis Capital may purchase up to 104,167
post-split shares of the Company's Common Stock at an exercise price of $2.40
per share for a one-year period. The Series B Convertible Debenture and Series
D, E, and F Common Stock Purchase Warrants may not be converted and exercised to
the extent that Vicis Capital's overall ownership of the Company's Common Stock,
giving effect to that conversion and together with the right to receive any
Common Stock within sixty days of the conversion date, will exceed 4.99% of the
Company's outstanding stock at that time.

NOTE G - MERGER AGREEMENT

On May 11, 2005 the Company executed a Merger Agreement (the "Merger Agreement")
by and among AFMN, Inc., a Delaware corporation ("AFMN"), African American
Medical Network, Inc., a Florida corporation ("African American Medical
Network"), and AAMN Acquisition Sub, Inc. ("AAMN Acquisition Sub") whereby the
Company will acquire 100% of the capital stock of African American Medical
Network in exchange for 14,865,657 shares of our Common Stock. African American
Medical Network provides educational programming to patients through
installation of TV/DVD viewing systems in doctors' offices serving the African
American population. Pursuant to the terms of the Merger Agreement, AAMN
Acquisition Sub will be merged with and into African American Medical Network,
and AFMN will receive the aforementioned shares of Medical Media in exchange for
all of the outstanding shares of capital stock of African American Medical
Network owned by AFMN. Pursuant to the terms of the Merger Agreement, the
Company intends to file a Registration Statement on Form S-4 ("Form S-4") with
the Securities and Exchange Commission (the "SEC") registering the 14,865,657
shares of Common Stock the Company will issue to AFMN. The closing of the Merger
Agreement will occur within three (3) business days of the date upon which the
Form S-4 is declared effective by the SEC. The Company intends to file the Form
S-4 as soon as practical. Further details regarding the First Amendment to the
Merger Agreement is contained in Subsequent Events.

NOTE H - SUBSEQUENT EVENTS

On November 16, 2005, the Company executed that certain First Amendment to
Merger Agreement by and among the Company, AFMN, Inc., a Delaware corporation
("AFMN"), African American Medical Network, Inc., a Florida corporation
("African American Medical Network"), and AAMN Acquisition Sub, Inc., a Florida
corporation ("AAMN Acquisition Sub"), whereby the parties amended that certain
Merger Agreement dated May 11, 2005 to reflect the following material items:

      o     Medical Media would issue 19,415,626 shares of its restricted common
            stock to AFMN in exchange for 100% of the outstanding shares of
            African American Medical Network;

                                       19
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE H - SUBSEQUENT EVENTS (Continued)

      o     Medical Media would file, as soon as practicable, an appropriate
            registration statement with the Securities and Exchange Commission
            registering the Medical Media Common Stock issued to AFMN pursuant
            to the Merger. In addition to the foregoing, AFMN has agreed to
            distribute the Medical Media Common Stock pro-rata to its
            shareholders of record as of November 16, 2005.

      o     Prior to registration of the Medical Media Common Stock issued to
            AFMN pursuant to the Merger, the parties agreed that the Medical
            Media Common Stock would be held in escrow along with distribution
            instructions to effect the pro-rata distribution referenced in the
            preceding paragraph. The parties further agreed that, while the
            Medical Media Common Stock is held in escrow, Philip Cohen will hold
            sole voting rights over the shares pursuant to an irrevocable proxy
            delivered by AFMN to Mr. Cohen.

      o     All issued and outstanding convertible securities of AFMN would be
            exchanged for equivalent convertible securities of Medical Media on
            a one-for-one basis and all issued and outstanding warrants to
            purchase AFMN common stock would be exchanged for equivalent Medical
            Media warrants on a one-for-one basis. All convertible securities
            and warrants exchanged shall be governed by the same terms and
            conditions as were applicable to the securities prior to the
            effective date of the Merger.

      On November 16, 2005, the parties consummated the Merger in accordance
with the terms of the Merger Agreement. In connection with the same, the parties
filed Articles of Merger with the Florida Department of State whereby AAMN
Acquisition Sub was merged with and into African American Medical Network, with
African American Medical Network being the surviving entity. As a result of the
Merger, African American Medical Network is now a wholly-owned subsidiary of
Medical Media.

      Pursuant to the Merger Agreement, as amended, Medical Media issued
19,415,626 shares of its restricted Common Stock to AFMN in exchange for 100% of
the outstanding shares of African American Medical Network. The Company issued
the Medical Media Common Stock in the name of AFMN and deposited the same in
escrow pending the registration of the Medical Media Common Stock under the
Securities Act of 1933. The Medical Media Common Stock issued to AFMN pursuant
to the Merger Agreement was issued in reliance upon the exemption from
registration provided by Section 4(2) of the Securities Act of 1933, as amended.
Medical Media made no solicitation in connection with the transactions other
than communications with AFMN. The Medical Media Common Stock issued to AFMN was
issued with a restricted securities legend. No underwriting discounts or
commissions were paid in conjunction with the issuance of the shares.

      Prior to the consummation of the Merger Agreement, Philip Cohen owned
330,747 of the 1,309,478 issued and outstanding shares of the Medical Media
Common Stock. After consummation of the Merger Agreement, AFMN now owns
19,415,626 of the 20,725,104 shares of Medical Media Common Stock. AFMN has
executed and delivered an irrevocable proxy providing Philip Cohen with sole
voting power over the 19,415,626 shares of Medical Media Common Stock until said
shares are registered under the Securities Act of 1933 and distributed to the
AFMN shareholders of record as of November 16, 2005.

                                       20
<PAGE>

                         MEDICAL MEDIA TELEVISION, INC.
                          (A DEVELOPMENT STAGE COMPANY)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005

NOTE H - SUBSEQUENT EVENTS (Continued)

      The financial statements required by Item 9.01(a) of Form 8-K are not
included in this report. The Company will file the required financial statements
within 71 days of the filing date of this report. In addition, the pro forma
financial information required by Item 9.01(b) of Form 8-K is not included in
this report. The Company will file the required pro forma financial information
within 71 days of the filing date of this report.


                                       21
<PAGE>

Item 2. Management's Discussion and Analysis or Plan of Operation.

Overview

On April 21, 2005, PetCARE Television Network, Inc. changed its name to Medical
Media Television, Inc. ("Medical Media" or the "Company"; references to "we,"
"our" or "us" also mean the Company). Medical Media was organized as a Florida
corporation on October 2, 1989. On April 22, 2005, Medical Media organized a
wholly-owned subsidiary, PetCARE Television Network, Inc., a Florida corporation
("PetCARE TV"). Also on April 22, 2005, Medical Media organized AAMN Acquisition
Sub, Inc., a wholly-owned Florida corporation, for the purpose of acquiring
African American Medical Network, Inc.

On May 4, 2005, the Company combined its issued and outstanding Common Stock on
a 1:30 basis. On May 10, 2005, the Company issued a dividend of two (2) shares
of the Company's restricted Common Stock for each share of Common Stock held by
shareholders of record as of May 10, 2005 with a payment date of May 17, 2005.

On May 11, 2005 the Company executed a Merger Agreement (the "Merger Agreement")
by and among AFMN, Inc. a Delaware corporation ("AFMN"), African American
Medical Network, Inc. a Florida corporation ("African American Medical
Network"), and AAMN Acquisition Sub, Inc. ("AAMN Acquisition Sub") whereby the
Company would acquire 100% of the capital stock of African American Medical
Network in exchange for 14,865,657 shares of our Common Stock. African American
Medical Network provides educational programming to patients through
installation of TV/DVD viewing systems in doctors' offices serving the African
American population. Pursuant to the terms of the Merger Agreement, AAMN
Acquisition Sub would be merged with and into African American Medical Network,
and AFMN would receive the aforementioned shares of Medical Media in exchange
for all of the outstanding shares of capital stock of African American Medical
Network owned by AFMN. Pursuant to the terms of the Merger Agreement, the
Company intended to file a Registration Statement on Form S-4 ("Form S-4") with
the Securities and Exchange Commission (the "SEC") registering the 14,865,657
shares of Common Stock the Company would issue to AFMN. The closing of the
Merger Agreement would occur within three (3) business days of the date upon
which the Form S-4 was declared effective by the SEC. See "Subsequent Events"
for details regarding the First Amendment to the Merger Agreement and the
closing of the Merger Agreement.

We are a development stage company, and as such, have devoted our efforts since
inception to developing and implementing our business plan. Since the
commencement of the implementation of our current business plan (June 2002), we
have devoted our efforts to the following activities:

      o     Raising capital;

      o     Producing our programming;

      o     Securing advertisers for our programming;

      o     Securing equipment;

      o     Producing marketing materials for veterinarians and advertisers;

      o     Contracting for subscription audits;

      o     Securing veterinary office locations to show our programming;

      o     Shipping equipment and educational programming to veterinarians; and

      o     Establishing a presence at trade shows.

Our goal is to be recognized as a leading provider of advertiser-supported
patient/client medical education programming within the place-based media
environment of medical specialty offices nationwide.

                                       22
<PAGE>

Through PetCARE TV, we provide educational programming focused on optimal
healthcare for animal companions and targeted to pet owners. While pet owners
are seated in their veterinarian's reception area, our DVD magazine is played,
with an encouraging theme throughout each segment to "just ask" their
veterinarian about current techniques, products and services available. The
programming is funded, in part, by commercial advertisers that are reviewed and
approved by our Veterinary Advisory Board, a distinguished group of veterinary
professionals committed to providing quality educational, entertaining, and
encouraging veterinary health programming. Our programming is obtained through
an annual or three-year subscription, with a TV/DVD viewing system included in
the three-year plan. Updated DVD magazines are mailed monthly to all
subscribers.

We have expended approximately $4,600,000 through September 30, 2005 in
developing our business plan, which included placing systems in approximately
3,000 veterinary offices, and the completion of production, replication, and
delivery of our monthly DVD magazines. For the period from the implementation of
our current business plan (June 2002) through September 30, 2005, we have
generated revenue of $136,928 from advertising and $22,012 from sales of Welcome
Home Your New Friend (educational DVDs for new pet owners which are sold to
veterinarians who distribute them to their clients). Also during that period, we
generated revenue from subscription sales to veterinarian offices of $60,202 of
which $37,549 is recorded as deferred revenue.

PetCARE TV's website (www.petcaretv.com) was developed in cooperation with a
third party consultant. We use our website primarily as an information tool for
prospective subscribers and advertisers who can log on to find out about our
business. Prospective subscribers are allowed to view our current programming,
review frequently asked questions, review our subscription process, and print
out a subscription agreement.

Critical Accounting Policies and Estimates

Our financial statements have been prepared in accordance with accounting
principles generally accepted in the United States. The preparation of these
financial statements requires us to make significant estimates and judgments
that affect the reported amounts of assets, liabilities, revenues, expenses and
related disclosure of contingent assets and liabilities. We evaluate our
estimates, including those related to contingencies, on an ongoing basis. We
base our estimates on historical experience and on various other assumptions
that are believed to be reasonable under the circumstances, the results of which
form the basis for making judgments about the carrying values of assets and
liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions.

Revenue Recognition

We generate revenue from two primary sources, namely advertisers on PetCARE TV's
DVD magazines (the "Advertisers") and subscribers to its PetCARE TV network (the
"Subscribers"). With regard to Advertisers, revenue is recognized over the
periods in which the advertisers' commercials appear on the DVD magazine. With
regard to Subscribers, revenue is recognized proportionately over the length of
the subscription agreement entered into by the Subscribers.

Plan of Operations

Results of Operations - Inception (October 2, 1989) to September 30, 2005

From inception to September 30, 2005, we had losses totaling $5,873,657. For
this period, our general and administrative costs totaled $2,976,603 or 58% of
total operating expenses. DVD production costs

                                       23
<PAGE>

totaled $487,550 or 9% of total operating expenses, and sales and marketing
costs totaled $1,522,138 or 30% of total operating expenses. The remainder of
operating expense is represented by depreciation and amortization that totaled
$153,930 or 3% of total operating expenses.

Results of Operations - Comparison of Three Months Ending September 30, 2005 and
2004

For the three-month period ending September 30, 2005, we had losses totaling
$340,724, compared to losses of $530,899 for the same period in 2004. The
decrease of $190,175 is primarily a result of reductions in general and
administration and interest expense partially offset by an increase in sales and
marketing expense. For the three-month period ending September 30, 2005, our
general and administration costs totaled $171,950 compared to $232,629 for the
same period in 2004. Our DVD production costs totaled $32,447 for the period
ending September 30, 2005, compared to $58,521 for the same period in 2004. We
associate this change to the implementation of production efficiencies and other
cost saving methods. Our sales and marketing costs totaled $160,410 for the
three months ending September 30, 2005, compared to $123,443 for the same period
in 2004. This increase is a result of increases in personnel and trade show
expense. Depreciation and amortization costs totaled $1,663 for the three months
ended September 30, 2005.

Results of Operations - Comparison of Nine Months Ending September 30, 2005 and
2004

For the nine-month period ending September 30, 2005, we had losses totaling
$1,301,669, compared to losses of $1,646,603 for the same period in 2004. The
decrease of $344,934 is primarily a result of efficiencies in DVD production
costs, decreases in general and administration costs primarily as a result of
the reduction of fund raising costs in 2005 as compared to 2004, and reductions
in sales and marketing expense partially offset by increases in interest
expense. For the nine-month period ending September 30, 2005, our general and
administration costs totaled $586,417, compared to $847,508 for the same period
in 2004. This decrease of $261,091 is primarily attributed to fees and costs
related to our fund raising efforts during 2004 ($155,000). Our DVD production
costs totaled $109,570 for the period ending September 30, 2005, compared to
$161,325 for the same period in 2004. We associate this change to the
implementation of production efficiencies and other cost saving methods offset
by increased production costs related to the Company's conversion from quarterly
to monthly DVD distribution. Our sales and marketing costs totaled $351,437 for
the nine-months ending September 30, 2005, compared to $361,539 for the same
period in 2004. Depreciation and amortization costs totaled $2,409 for the nine
months ended September 30, 2005.

Liquidity and Capital Resources

As of November 21, 2005, we had cash on hand of approximately $18,000 which is
not sufficient to satisfy our operating requirements through December 2005. To
satisfy our operating requirements through December 2005, we estimate that we
will need an additional $250,000, however if we do not generate those revenues
or secure debt or equity financing before the end of December 2005 we may be
unable to sustain our current level of operations and may have to cut back or
shut down our operations at that time.

On May 16, 2002, we issued a non-interest bearing promissory note to James
Calaway, a shareholder and former director, in the original principal amount of
$100,000 (the "Calaway Note"). At September 30, 2005, the principal balance due
on the Calaway Note was $91,500.

In June 2002, we issued the following shareholders non-interest bearing
promissory notes (the "Hugo/Turner Notes"), all of which remained due and
payable at September 30, 2005:

                                       24
<PAGE>

      o     Daniel V. Hugo, a former officer/director, in the amount of $25,000;
      o     Robert and Janna Hugo, in the amount of $6,000; and
      o     Robert and Jamie Turner, in the amount of $5,000.

On March 10, 2003, May 28, 2003, June 6, 2003, and July 1, 2003 we entered into
Note Purchase and Security Agreement(s) and Senior Convertible Promissory
Note(s) (the "Edge Notes") with Pet Edge, LLC, a Connecticut limited liability
company ("Edge"). Under the terms of the Edge Notes, Edge loaned us $1,000,000,
$50,000, $50,000, and $275,000 respectively with simple interest at the rate of
ten percent (10%) per annum. All principal and accrued interest on the Edge
Notes was due March 9, 2006, May 27, 2006, June 5, 2006, and June 30, 2006
respectively and was convertible into pre-split shares of our Common Stock at
$.246 per share. On November 10, 2003, we entered into an agreement with Edge to
amend the terms of conversion of the Edge Notes (the "Edge Amendment"). Pursuant
to the terms of the Debt Exchange Agreement dated July 8, 2005 by and between
Edge and the Company ("Edge Debt Exchange Agreement") the Edge Notes were
converted into 1,682,044 shares of the Company's Series A Zero Coupon Preferred
Stock and 2,102,556 five-year Warrants to purchase shares of Common Stock of
Medical Media ("Edge Debt Exchange Warrants") at an exercise price of fifteen
cents ($.15).

On June 10, 2003, we entered into a Note Purchase Agreement and Convertible
Promissory Note with a former director, Mark Maltzer (the "Maltzer Note"). Under
the terms of the Maltzer Note, Dr. Maltzer agreed to loan us $50,000 with simple
interest at a rate of ten percent (10%) per annum. All principal and accrued
interest was due June 9, 2006 and was convertible into pre-split shares of
Common Stock of the Company at $.246 per share. Pursuant to the terms of the
Debt Exchange Agreement dated July 8, 2005 by and between Dr. Maltzer and the
Company ("Maltzer Debt Exchange Agreement") the Maltzer Note was converted into
60,411 shares of the Company's Series B Zero Coupon Preferred Stock and 45,308
five-year Warrants to purchase shares of Common Stock of Medical Media ("Maltzer
Debt Exchange Warrants) at an exercise price of fifteen cents ($.15).

On February 13, 2004, Medical Media entered into a Note Purchase Agreement with
Victus Capital, LP, a Delaware limited partnership ("Victus") and issued Victus
a Subordinated Convertible Promissory Note (the "Victus February Note"). Under
the terms of the Victus February Note, Victus loaned us $1,000,000 with interest
of $62,500 per quarter. In order to insure that interest payments were made,
$250,000 of the principal amount of the Victus February Note was delivered to an
escrow agent to be held for the purposes of making quarterly interest payments
to Victus. In May 2004, Medical Media issued 357,143 (11,905 post-split) shares
of its Common Stock at $.70 ($2.10 post-split) per share and 714,286 (23,810
post-split) Common Stock Purchase Warrants ("Victus February Warrants") in lieu
of $250,000 in interest due on the Victus February Note. Accordingly, the
$250,000 being held in escrow was released to the Company in exchange for the
shares and the Victus February Warrants. Each Victus February Warrant is
exercisable into the Company's Common Stock at $1.00 ($30.00 post-split) per
share at any time for five years from the date of issuance. On September 1,
2005, the Company reduced the exercise price of these warrants to $2.40. The
Victus February Note, the shares of Common Stock, and Victus February Warrants
were issued under the exemption from registration provided in Section 4(2) of
the Securities Act of 1933 (the "Securities Act"). In March 2005, Vicis Capital
Master Fund, a fund managed by Vicis Capital, LP, a Delaware limited partnership
("Vicis Capital") acquired certain assets of Victus. Included in the acquisition
were the Victus February Note, the shares of the Company's Common Stock, and the
Victus February Warrants discussed above. Pursuant to the terms of a Debt
Exchange Agreement dated July 8, 2005 between Vicis Capital and the Company, the
Victus February Note was converted into 1,100,000 shares of the Company's Series
B Zero Coupon Preferred Stock and 825,000 five-year Warrants to purchase shares
of Common Stock of Medical Media ("Vicis Capital Debt Exchange Warrants") at an
exercise price of fifteen cents ($.15).

                                       25
<PAGE>

On July 27, 2004, Medical Media entered into a Note Purchase Agreement with
Victus Capital and issued a Subordinated Convertible Promissory Note ("Victus
July Note"), and Warrant to Purchase Shares of Common Stock (the "Victus July
Warrant"). Under the terms of the Victus July Note, Victus loaned us $1,000,000
at an annual rate of interest of twenty percent (20%) compounded semi-annually.
The Victus July Note had a term of twelve months. On the date of maturity, the
Victus July Note was convertible, at the option of the holder, into shares of
our Common Stock at $.40 per share. Pursuant to the terms of the Victus July
Warrant, Victus may purchase up to 2,500,000 (83,333 post-split) shares of our
Common Stock at an exercise price of $0.75 ($22.50 post-split) per share until
the expiration date of July 26, 2009. On September 1, 2005, the Company reduced
the exercise price of these warrants to $2.40. The Victus July Note could not be
converted and the Victus July Warrant may not be exercised to the extent that
Victus' overall ownership of the Company's Common Stock exceeds 4.99%, unless
such limitation is waived by Victus upon no less than sixty-one days (61)
advance written notice. In March 2005, Vicis Capital acquired certain assets of
Victus. Included in the acquisition were the Victus July Note and the Victus
July Warrant discussed above. Pursuant to the terms of a Debt Exchange Agreement
dated July 8, 2005 between Vicis Capital and the Company, the Victus July Note
was converted into 1,189,589 shares of the Company's Series B Zero Coupon
Preferred Stock and 892,192 Vicis Capital Exchange Warrants to purchase shares
of Common Stock of Medical Media at an exercise price of fifteen cents ($.15).

On July 28, 2004, in connection with the Victus July Note, the Company issued
TotalCFO, LLC a Warrant to Purchase Shares of Common Stock for 300,000 (10,000
post-split) shares of the Company's Common Stock at $0.75 ($22.50 post-split)
per share over a period of five years. On September 1, 2005, the Company reduced
the exercise price of these warrants to $2.40.

On March 11, 2005, the Company issued to Vicis Capital its Series A Convertible
Debentures ("Series A Debentures"), Series A Common Stock Purchase Warrants,
Series B Common Stock Purchase Warrants, and Series C Common Stock Purchase
Warrants pursuant to the exemption from registration found in Section 4(2) of
Regulation D under the Securities Act of 1933. Pursuant to the terms of the
Series A Debentures, Vicis Capital loaned the Company an aggregate of $250,000
at an annual rate of interest of fifteen percent (15%). The Series A Debentures
had a term of 24 months and the Company had the option to pay the interest
semi-annually in cash or in shares of its registered Common Stock at a ten
percent (10%) discount to the market price based on the average of the twenty
(20) trading days prior to the payment of the interest. On the date of maturity
of the Series A Debentures, Vicis Capital had the option to convert the Series A
Debentures into shares of the Company's Common Stock at a price of $0.10 ($3.00
post-split) per share. Under the terms of the Series A Common Stock Purchase
Warrants, Vicis Capital may purchase up to 2,500,000 (83,335 post-split) shares
of the Company's Common Stock at an exercise price of $0.10 ($3.00 post-split)
per share for a ten-year period. On September 1, 2005, the Company reduced the
exercise price of these warrants to $2.40. Under the terms of the Series B
Common Stock Purchase Warrants, Vicis Capital may purchase up to 2,500,000
(83,335 post-split) shares of the Company's Common Stock at an exercise price of
$0.125 ($3.75 post-split) per share for a five-year period. On September 1,
2005, the Company reduced the exercise price of these warrants to $2.40. Under
the terms of the Series C Common Stock Purchase Warrants, Vicis Capital may
purchase up to 1,250,000 (41,670 post-split) shares of the Company's Common
Stock at an exercise price of $.10 ($3.00 post-split) per share for a one-year
period. On September 1, 2005, the Company reduced the exercise price of these
warrants to $2.40. The Series A Debentures and Series A, B, and C Common Stock
Purchase Warrants may not be converted and exercised to the extent that Vicis
Capital's overall ownership of the Company's Common Stock exceeds 4.99%, unless
such limitation is waived by Vicis Capital upon no less than sixty-one days (61)
advance written notice. Pursuant to the terms of a Debt Exchange Agreement dated
July 8, 2005 between Vicis Capital and the Company, the Series A Debentures were
converted into 262,329 shares of the Company's Series B Zero Coupon Preferred
Stock and 196,747 Vicis Capital Exchange Warrants to purchase shares of Common
Stock of Medical Media at an exercise price of fifteen cents ($.15).

                                       26
<PAGE>

As a result of fees incurred in connection with the Series A Debentures
mentioned above, the Company issued Common Stock Purchase Warrants to MidTown
Partners & Co., LLC to purchase 50,000 (1,667 post-split) shares of the
Company's Common Stock at an exercise price of $.10 (3.00 post-split) per share
for a term of five (5) years. On September 1, 2005, the Company reduced the
exercise price of these warrants to $2.40.

On May 6, 2005, the Company issued to Vicis Capital its Series B Convertible
Debenture ("Series B Convertible Debenture"), Series D Common Stock Purchase
Warrants, Series E Common Stock Purchase Warrants, and Series F Common Stock
Purchase Warrants pursuant to the exemption from registration found in Section
4(2) of Regulation D under the Securities Act of 1933. Pursuant to the terms of
the Series B Convertible Debenture, Vicis Capital loaned the Company an
aggregate of $250,000 at an annual rate of interest of fifteen percent (15%).
The Series B Convertible Debenture has a term of 24 months and the Company has
the option to pay the interest semi-annually in cash or in shares of its
registered Common Stock at a ten percent (10%) discount to the market price
based on the average five (5) days Volume Weighted Average Closing Price of the
Company's Common Stock for the five (5) trading days prior to payment. On the
date of maturity of the Series B Convertible Debenture, Vicis Capital has the
option to convert the Series B Convertible Debenture into post-split shares of
the Company's Common Stock at a price of $2.40 per share. Under the terms of the
Series D Common Stock Purchase Warrants, Vicis Capital may purchase up to
104,167 post-split shares of the Company's Common Stock at an exercise price of
$2.40 per share for a ten (10) year period. Under the terms of the Series E
Common Stock Purchase Warrants, Vicis Capital may purchase up to 104,167
post-split shares of the Company's Common Stock at an exercise price of $2.40
per share for a five (5) year period. Under the terms of the Series F Common
Stock Purchase Warrants, Vicis Capital may purchase up to 104,167 post-split
shares of the Company's Common Stock at an exercise price of $2.40 per share for
a one-year period. The Series B Convertible Debenture and Series D, E, and F
Common Stock Purchase Warrants may not be converted and exercised to the extent
that Vicis Capital's overall ownership of the Company's Common Stock, giving
effect to that conversion and together with the right to receive any Common
Stock within sixty days of the conversion date, will exceed 4.99% of the
Company's outstanding stock at that time.

As a result of fees incurred in connection with the Series B Debentures
mentioned above, the Company issued Series D Common Stock Purchase Warrants to
MidTown Partners & Co., LLC to purchase 20,000 post-split shares of the
Company's Common Stock at an exercise price of $2.40 per share for a term of
five years.

Zero Coupon Preferred Stock

The Board of Directors of Medical Media approved the Certificates of
Designations, Preferences, Rights and Limitations for Series A Zero Coupon
Preferred Stock and Series B Zero Coupon Preferred Stock. The Company filed an
amendment to its articles of incorporation on July 14, 2005 which authorized
1,682,044 shares of Series A Zero Coupon Preferred Stock with $1.00 Stated Value
and 2,612,329 shares of Series B Zero Coupon Preferred Stock with $1.00 Stated
Value. The Series A Zero Coupon Preferred Stock and Series B Zero Coupon
Preferred Stock are convertible into the Company's Common Stock at the option of
the holder any time after the date of issuance at the rate of $2.40 and $3.00
per share respectively. The holders of the Series A Zero Coupon Preferred Stock
and Series B Zero Coupon Preferred Stock will be entitled to receive, when and
as declared by the Board of Directors, if at all, dividends on parity with each
holder of one or more shares of the Common Stock. Any dividend or other
distribution meeting these requirements will be payable in an amount equal to
the product of (a) the dividend payable on each share of Common Stock and (b)
the number of shares of Common Stock issuable upon conversion of a share of
Series A Zero Coupon Preferred Stock and Series B Zero Coupon Preferred Stock,
in each case, calculated on the record date for determination of holders
entitled to receive such dividend.

                                       27
<PAGE>

From inception through September 30, 2005, we incurred interest expense of
approximately $891,000. This amount includes accrued interest totaling
approximately $15,000 related to the Series B Debenture, $619,000 converted into
Preferred Stock as related to the Edge Notes, the Maltzer Note, and the Victus
February Note, Victus July Note, and the Series A Debentures. It also includes
$250,000 payment of interest related to the Victus February Note (in May 2004,
we issued 357,143 (11,905 post-split) shares of our Common Stock at $.70 ($21.00
post-split) per share and 714,286 (23,810 post-split) Common Stock Purchase
Warrants in lieu of $250,000 in interest due) and approximately $7,000 in
interest paid.

If we do not generate revenues or secure debt or equity financing, we will be
unable to pay one or more of the obligations referenced above.

Forward-Looking Statements. Information included or incorporated by reference in
this Form 10-QSB may contain forward-looking statements, which we believe are
within the meaning of the Securities Exchange Act of 1934, as amended. This
information may involve known and unknown risks, uncertainties and other factors
which may cause our actual results, performance or achievements to be materially
different from the future results, performance or achievements expressed or
implied by any forward-looking statements. Forward-looking statements, which
involve assumptions and describe our future plans, strategies and expectations,
are generally identifiable by use of the words "may," "will," "should,"
"expect," "anticipate," "estimate," "believe," "intend" or "project," or the
negative of these words or other variations on these words or comparable
terminology.

Item 3. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, the Company carried out an
evaluation, under the supervision and with the participation of the Company's
Principal Executive Officer and Principal Financial Officer of the effectiveness
of the design and operation of the Company's disclosure controls and procedures.
The Company's disclosure controls and procedures are designed to ensure that
information required to be disclosed by us in the reports we file or submit
under the Exchange Act is recorded, processed, summarized and reported, within
the time periods specified in the Securities and Exchange Commission's rules and
forms. The Company's Principal Executive Officer and Principal Financial Officer
have concluded that the Company's disclosure controls and procedures are, in
fact, effective at this reasonable assurance level as of the period covered.

Changes in Internal Controls Over Financial Reporting

In connection with the evaluation of the Company's internal controls during the
Company's quarter ended September 30, 2005, the Company's Principal Executive
Officer and Principal Financial Officer have determined that there are no
changes to the Company's internal controls over financial reporting that have
materially affected, or are reasonably likely to materially effect, the
Company's internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

                                       28
<PAGE>

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults upon Senior Securities.

None.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

Item 5. Other Information.

Subsequent Events

On November 16, 2005, the Company executed that certain First Amendment to
Merger Agreement by and among the Company, AFMN, Inc., a Delaware corporation
("AFMN"), African American Medical Network, Inc., a Florida corporation
("African American Medical Network"), and AAMN Acquisition Sub, Inc., a Florida
corporation ("AAMN Acquisition Sub"), whereby the parties amended that certain
Merger Agreement dated May 11, 2005 to reflect the following material items:

      o     Medical Media would issue 19,415,626 shares of its restricted common
            stock to AFMN in exchange for 100% of the outstanding shares of
            African American Medical Network;

      o     Medical Media would file, as soon as practicable, an appropriate
            registration statement with the Securities and Exchange Commission
            registering the Medical Media Common Stock issued to AFMN pursuant
            to the Merger. In addition to the foregoing, AFMN has agreed to
            distribute the Medical Media Common Stock pro-rata to its
            shareholders of record as of November 16, 2005.

      o     Prior to registration of the Medical Media Common Stock issued to
            AFMN pursuant to the Merger, the parties agreed that the Medical
            Media Common Stock would be held in escrow along with distribution
            instructions to effect the pro-rata distribution referenced in the
            preceding paragraph. The parties further agreed that, while the
            Medical Media Common Stock is held in escrow, Philip Cohen will hold
            sole voting rights over the shares pursuant to an irrevocable proxy
            delivered by AFMN to Mr. Cohen.

      o     All issued and outstanding convertible securities of AFMN would be
            exchanged for equivalent convertible securities of Medical Media on
            a one-for-one basis and all issued and outstanding warrants to
            purchase AFMN common stock would be exchanged for equivalent Medical
            Media warrants on a one-for-one basis. All convertible securities
            and warrants exchanged shall be governed by the same terms and
            conditions as were applicable to the securities prior to the
            effective date of the Merger.

On November 16, 2005, the parties consummated the Merger in accordance with the
terms of the Merger Agreement. In connection with the same, the parties filed
Articles of Merger with the Florida Department of State whereby AAMN Acquisition
Sub was merged with and into African American Medical Network, with African
American Medical Network being the surviving entity. As a result of the Merger,
African American Medical Network is now a wholly-owned subsidiary of Medical
Media.

                                       29
<PAGE>

Pursuant to the Merger Agreement, as amended, Medical Media issued 19,415,626
shares of its restricted Common Stock to AFMN in exchange for 100% of the
outstanding shares of African American Medical Network. The Company issued the
Medical Media Common Stock in the name of AFMN and deposited the same in escrow
pending the registration of the Medical Media Common Stock under the Securities
Act of 1933. The Medical Media Common Stock issued to AFMN pursuant to the
Merger Agreement was issued in reliance upon the exemption from registration
provided by Section 4(2) of the Securities Act of 1933, as amended. Medical
Media made no solicitation in connection with the transactions other than
communications with AFMN. The Medical Media Common Stock issued to AFMN was
issued with a restricted securities legend. No underwriting discounts or
commissions were paid in conjunction with the issuance of the shares.

Prior to the consummation of the Merger Agreement, Philip Cohen owned 330,747 of
the 1,309,478 issued and outstanding shares of the Medical Media Common Stock.
After consummation of the Merger Agreement, AFMN now owns 19,415,626 of the
20,725,104 shares of Medical Media Common Stock. AFMN has executed and delivered
an irrevocable proxy providing Philip Cohen with sole voting power over the
19,415,626 shares of Medical Media Common Stock until said shares are registered
under the Securities Act of 1933 and distributed to the AFMN shareholders of
record of November 16, 2005.

The financial statements required by Item 9.01(a) of Form 8-K are not included
in this report. The Company will file the required financial statements within
71 days of the filing date of this report. In addition, the pro forma financial
information required by Item 9.01(b) of Form 8-K is not included in this report.
The Company will file the required pro forma financial information within 71
days of the filing date of this report.

Item 6. Exhibits.

      3.1   Amended and Restated Articles of Incorporation, previously filed as
            an Exhibit to the Company's Registration Statement on Form SB-2
            filed with the Commission on June 4, 2003, as amended, are
            incorporated herein by reference.

      3.2   Articles of Amendment to the Articles of Incorporation previously
            filed as an Exhibit to the Company's Registration Statement on Form
            SB-2 filed with the Commission on June 4, 2003, as amended, are
            incorporated herein by reference.

      3.3   Articles of Amendment to the Articles of Incorporation, previously
            filed as an Exhibit to the Company's Registration Statement on Form
            SB-2 filed with the Commission on June 4, 2003, as amended, are
            incorporated herein by reference.

      3.4   Articles of Amendment to the Articles of Incorporation, previously
            filed as an Exhibit to the Company's Quarterly Report on Form 10-QSB
            filed with the Commission on August 18, 2004, are incorporated
            herein by reference.

      3.5   Articles of Amendment to the Articles of Incorporation, previously
            filed as an Exhibit to the Company's Annual Report on Form 10-KSB
            filed with the Commission on March 31, 2005, are incorporated herein
            by reference.

                                       30
<PAGE>

      3.6   Articles of Amendment to the Articles of Incorporation, previously
            filed as an Exhibit to the Company Quarterly Report on Form 10-QSB
            filed with the Commission on May 16, 2005, are incorporated herein
            by reference.

      3.7   Articles of Amendment to the Articles of Incorporation filed on July
            15, 2005.

     *3.8   Articles of Merger filed on November 16, 2005.

      3.9   Bylaws of PetCARE Television Network, Inc. previously filed as an
            Exhibit to the Company's Registration Statement on Form SB-2 filed
            with the Commission on June 4, 2003, as amended, are incorporated
            herein by reference.

      10.00 Debt Exchange Agreement between the Company and Pet Edge, LLC dated
            July 8, 2005 previously filed as an Exhibit to the Company's Form
            10-QSB filed with the Commission on August 9, 2005, is incorporated
            herein by reference.

      10.01 Debt Exchange Agreement between the Company and Mark Maltzer dated
            July 8, 2005 previously filed as an Exhibit to the Company's Form
            10-QSB filed with the Commission on August 9, 2005, is incorporated
            herein by reference.

      10.02 Debt Exchange Agreement between the Company and Vicis Capital Master
            Fund dated July 8, 2005 previously filed as an Exhibit to the
            Company's Form 10-QSB filed with the Commission on August 9, 2005,
            is incorporated herein by reference.

      10.03 Common Stock Purchase Warrant issued to Pet Edge, LLC dated July 8,
            2005 previously filed as an Exhibit to the Company's Form 10-QSB
            filed with the Commission on August 9, 2005, is incorporated herein
            by reference.

      10.04 Common Stock Purchase Warrant issued to Mark Maltzer dated July 8,
            2005 previously filed as an Exhibit to the Company's Form 10-QSB
            filed with the Commission on August 9, 2005, is incorporated herein
            by reference.

      10.05 Common Stock Purchase Warrant issued to Vicis Capital Master Fund
            dated July 8, 2005 previously filed as an Exhibit to the Company's
            Form 10-QSB filed with the Commission on August 9, 2005, is
            incorporated herein by reference.

     *10.06 First Amendment to the Merger Agreement by and among African
            American Medical Network, Inc., AFMN, Inc., Medical Media
            Television, Inc., and AAMN Acquisition Sub, Inc. dated November 16,
            2005.

     *10.07 Capital Stock Escrow and Disposition Agreement between the Company,
            AFMN, Inc., and Philip Cohen dated November 16, 2005.

     *31.1  Written Statement of Chief Executive Officer pursuant to Section 302
            of the Sarbanes-Oxley Act of 2002.

     *31.2  Written Statement of Chief Financial Officer pursuant to Section 302
            of the Sarbanes-Oxley Act of 2002.

     *32.1  Written Statement of Chief Executive Officer pursuant to Section 906
            of the Sarbanes-Oxley Act of 2002.

     *32.2  Written Statement of Chief Financial Officer pursuant to Section 906
            of the Sarbanes-Oxley Act of 2002.

  * Filed herewith.

                                       31
<PAGE>

                                   SIGNATURES

      In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.



Dated: November 21, 2005                 MEDICAL MEDIA TELEVISION, INC.



                                         By:      /s/ Philip M. Cohen
                                            ----------------------------------
                                              Philip M. Cohen, President and
                                              Chief Executive Officer



                                         By:      /s/ Donald R. Mastropietro
                                            ----------------------------------
                                              Donald  R. Mastropietro,
                                              Vice President Finance and
                                              Chief Financial Officer

                                       32